Leap Therapeutics | ARS: Annual Report to Security Holders
Leap Therapeutics | DEFA14A: Others
Leap Therapeutics | DEF 14A: Definitive information statements
Leap Therapeutics | SC 13G: Statement of acquisition of beneficial ownership by individuals-Samsara BioCapital, L.P.(6.4%),Samsara BioCapital GP, LLC(6.4%), etc.
Leap Therapeutics | 3: Initial statement of beneficial ownership of securities-10% Owner GILEAD SCIENCES, INC.
Leap Therapeutics | SC 13G: Statement of acquisition of beneficial ownership by individuals-Gilead Sciences, Inc.(13.9%)
Leap Therapeutics | 8-K: Current report
Leap Therapeutics | S-3: Registration statement for specified transactions by certain issuers
Leap Therapeutics | 8-K: Leap Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results
Leap Therapeutics | 10-K: Annual report
Leap Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Perceptive Advisors LLC(4.0%),Joseph Edelman(4.0%), etc.
Leap Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Mashiach Nissim
Leap Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Dietz Thomas John
Leap Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Schilsky Richard
Leap Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Granfield Christine
Leap Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Baum Jason
Leap Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Richard Christian M
Leap Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer O'Mahony John Mark
Leap Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Sirard Cynthia
Leap Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Martin Patricia A.
No Data